Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye.

Raghuram, A; Saravanan, V R; Narendran, V

Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye.

Date

2007-11-24

Authors

Raghuram, A

Saravanan, V R

Narendran, V

Abstract

Intracameral injection of bevacizumab (Avastin) helped in the successful regression of an anterior chamber neovascular membrane in a painful blind eye. The effect was persistent even after six months of follow-up. This is the first report on intracameral administration of bevacizumab with six months of follow-up.

Citation

Raghuram A, Saravanan VR, Narendran V. Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye. Indian Journal of Ophthalmology. 2007 Nov-Dec; 55(6): 460-2